Skip to product information
1 of 1

yuansensetech

PNC 27

PNC 27

4 total reviews

Regular price $130.00
Regular price Sale price $130.00
Sale Sold out
Shipping calculated at checkout.
Dosage
Quantity

Product Description

Overview

PNC-27 is a synthetic 32-residue chimeric anticancer peptide composed of an HDM-2 binding domain corresponding to residues 12–26 of the p53 protein and a cell-penetrating peptide (CPP) leader sequence. The compound belongs to a class of peptides designed to selectively target cancer cells while sparing normal, untransformed cells. PNC-27 has demonstrated potent antitumor activity against a wide range of cancer cell lines, including acute myeloid leukemia, cervical squamous cancer, ovarian cancer, colon cancer, and pancreatic carcinoma.

Mechanism of Action

PNC-27 exerts its selective anticancer effects through a unique dual-targeting mechanism. The peptide binds to the p53 binding site of HDM-2 (residues 1–109), a protein that is uniquely expressed on the plasma membranes of cancer cells but not on normal cells. Following binding, PNC-27 induces the formation of transmembrane pores, resulting in the extrusion of intracellular contents and cancer cell necrosis. Additionally, PNC-27 enters cancer cells and binds to mitochondrial membranes, causing mitochondrial disruption. The peptide exhibits selective cytotoxicity across a broad range of cancer types while demonstrating no effect on normal cells.

Research Applications
  • Acute Myeloid Leukemia: Investigated for its potent anti-leukemic activity, with in vivo studies demonstrating efficacy via intraperitoneal administration.
  • Ovarian Cancer: Studied for efficacy against both treatment-naïve and chemotherapy-resistant ovarian cancer cell lines, with demonstrated synergism when combined with paclitaxel.
  • Cervical Cancer: Employed in research on squamous cervical cancer, with selective killing of cancer cells while sparing normal cervical cells.
  • Colon Cancer: Investigated for selective killing of colon cancer stem cells.
  • Combination Therapy Studies: Explored in combination with conventional chemotherapeutic agents to overcome drug resistance.
Product Specifications

CAS Number: 1159861-00-3
Molecular Formula: C₁₈₈H₂₉₃N₅₃O₄₄S
Molecular Weight: 4,031.73 g/mol
Sequence: H-Pro-Pro-Leu-Ser-Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Lys-Lys-Trp-Lys-Met-Arg-Arg-Asn-Gln-Phe-Trp-Val-Lys-Val-Gln-Arg-Gly-OH
Purity: ≥ 99%
Form: Lyophilized powder
Storage: Store at ≤ -20°C in a cool, dry place, protected from light and moisture
Solubility: Soluble in sterile water and DMSO; prepare working solutions per laboratory protocol

View full details

Research Use Only

This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.